Cargando…
Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results
Based on numerous pharmacological studies that have revealed an interaction between cannabinoid and opioid systems at the molecular, neurochemical, and behavioral levels, a new series of hybrid molecules has been prepared by coupling the molecular features of two wellknown drugs, ie, rimonabant and...
Autores principales: | Fernández-Fernández, Cristina, Callado, Luis F, Girón, Rocío, Sánchez, Eva, Erdozain, Amaia M, López-Moreno, José Antonio, Morales, Paula, Rodríguez de Fonseca, Fernando, Fernández-Ruiz, Javier, Goya, Pilar, Meana, J Javier, Martín, M Isabel, Jagerovic, Nadine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934591/ https://www.ncbi.nlm.nih.gov/pubmed/24591816 http://dx.doi.org/10.2147/DDDT.S55045 |
Ejemplares similares
-
Benzyl-1,2,4-triazoles as CB(1) Cannabinoid Receptor Ligands: Preparation and In Vitro Pharmacological Evaluation
por: Hernandez-Folgado, Laura, et al.
Publicado: (2016) -
Allosteric Modulators of the CB(1) Cannabinoid Receptor: A Structural Update Review
por: Morales, Paula, et al.
Publicado: (2016) -
Rimonabant for treating tobacco dependence
por: Steinberg, Michael B, et al.
Publicado: (2007) -
Rimonabant: From RIO to Ban
por: Sam, Amir H., et al.
Publicado: (2011) -
Rimonabant, Gastrointestinal Motility and Obesity
por: Sun, Yan, et al.
Publicado: (2012)